You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

COVID-19 Resource Center

Healthcare professionals can find help and guidance on how to benefit from our offerings to treat your patients, as well as other practical information and advice.

Read more

Nyheter

Reporting period January – September

Reporting period January – September

• Orders received increased by 15.7% to SEK 13,809 million (11,933), corresponding to organic growth of 8.0%
• Orders received for the quarter increased by 15.8% to SEK 4,624 million (3,993), corresponding to organic growth of 10.2%
• Net sales rose by 13.8% to SEK 12,849 million (11,288)
• Profit before tax increased by 24.7% to SEK 1,089 million (873)
• Net profit increased by 26.5% to SEK 784 million (620)
• Earnings per share increased by 26.4% to SEK 3.73 (2.96)
• EBITA before restructuring rose by 27.8% to SEK 2,020 million (1,581)
• Continued strong earnings outlook for the year.
• Public offer for Datascope Corp.
• Increased new share issue creates financial flexibility.

Files

Del: